STOCK TITAN

Illumina Inc (ILMN) Financials

ILMN
Trailing 12 months to June 28, 2026
Revenue $4.5B +4.9% YoY
Net Income $825.0M -34.4% YoY
EPS (Diluted) $5.36 -32.2% YoY
Free Cash Flow $931.0M -9.7% YoY
Market Cap $41.2B as of Oct 3, 2026
Price / Sales 9.2x on $4.5B revenue, trailing 12 months to June 28, 2026
Price / Earnings 50.0x on $825.0M net income, trailing 12 months to June 28, 2026
Price / Book 14.5x on $2.8B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 28, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ILMN SEC filings page.

Illumina Inc (ILMN) reported $4.5B in revenue over the twelve months to Jun 28, 2026, up 4.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ILMN FY2025

Illumina restored profitability without growing sales, using a leaner cost base and converting earnings into strong cash generation.

FY2025’s operating margin reached 18.6% even as revenue stayed roughly flat and gross margin was 66.1%, pointing to an expense reset rather than volume-driven improvement. Operating cash flow of $1.08B exceeded net income of $850M, showing that the earnings recovery was accompanied by cash generation rather than relying mainly on accounting adjustments.

The cost structure did the heavy lifting: SG&A plus R&D fell to $2.05B in FY2025 from $2.26B in FY2024 while revenue remained near $4.3B. That combination explains why profitability improved far more than gross margin, which rose only from 65.4% to 66.1%.

Cash generation now reinforces the income statement: FY2025 operating cash flow exceeded net income, while free cash flow reached $931M. The company also used $742M for buybacks, reducing shares from 158.4M to 152.9M and returning capital during the same period that profitability recovered.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 44 / 100
Financial Health Score 44/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Illumina Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
29

Illumina Inc has an operating margin of 18.6%, meaning the company retains $19 of operating profit per $100 of revenue. This below-average margin results in a low score of 29/100, suggesting thin profitability after operating expenses. This is up from -19.1% the prior year.

Growth
25

Illumina Inc's revenue declined 0.7% year-over-year, from $4.4B to $4.3B. This contraction results in a growth score of 25/100.

Leverage
39

Illumina Inc has a moderate D/E ratio of 1.44. This balance of debt and equity financing earns a leverage score of 39/100.

Liquidity
61

Illumina Inc's current ratio of 2.08 indicates adequate short-term liquidity, earning a score of 61/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
81

Illumina Inc converts 21.4% of revenue into free cash flow ($931.0M). This strong cash generation earns a score of 81/100.

Returns
30

Illumina Inc's ROE of 31.2% shows moderate profitability relative to equity, earning a score of 30/100. This is up from -51.5% the prior year.

Altman Z-Score Safe
7.59

Illumina Inc scores 7.59, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($41.2B) relative to total liabilities ($3.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

Illumina Inc passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.27x

For every $1 of reported earnings, Illumina Inc generates $1.27 in operating cash flow ($1.1B OCF vs $850.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
7.99x

Illumina Inc earns $7.99 in operating income for every $1 of interest expense ($807.0M vs $101.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.2B
YoY+9.4%
QoQ+6.2%
5Y CAGR+1.2%
10Y CAGR+7.7%

Illumina Inc generated $1.2B in revenue in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 6.2%.

EBITDA
$315.0M
YoY+11.7%
QoQ+13.3%
5Y CAGR+5.5%

Illumina Inc's EBITDA was $315.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.7% from the same quarter a year earlier. Against the prior quarter it is up 13.3%.

Net Income
$207.0M
YoY-11.9%
QoQ+54.5%
5Y CAGR+7.1%
10Y CAGR+5.8%

Illumina Inc reported $207.0M in net income in Q2 2026. This represents a decrease of 11.9% from the same quarter a year earlier. Against the prior quarter it is up 54.5%.

EPS (Diluted)
$1.35
YoY-9.4%
QoQ+55.2%
5Y CAGR+6.2%
10Y CAGR+5.5%

Illumina Inc earned $1.35 per diluted share (EPS) in Q2 2026. This represents a decrease of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 55.2%.

Cash & Balance Sheet

Free Cash Flow
$161.0M
YoY-21.1%
QoQ-35.9%
5Y CAGR-7.7%
10Y CAGR+0.6%

Illumina Inc generated $161.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 21.1% from the same quarter a year earlier. Against the prior quarter it is down 35.9%.

Cash & Debt
$1.0B
YoY+11.3%
QoQ-4.5%
5Y CAGR-25.2%
10Y CAGR+6.5%

Illumina Inc held $1.0B in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
151M
YoY-1.8%
QoQ-0.2%
5Y CAGR+0.7%
10Y CAGR+0.3%

Illumina Inc had 151M shares outstanding in Q2 2026. This represents a decrease of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
66.4%
YoY+0.8pp
QoQ+0.3pp
5Y change-3.5pp
10Y change-4.0pp

Illumina Inc's gross margin was 66.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin
21.1%
YoY+0.9pp
QoQ+2.0pp
5Y change+3.5pp

Illumina Inc's operating margin was 21.1% in Q2 2026, reflecting core business profitability. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.

Net Margin
17.9%
YoY-4.3pp
QoQ+5.6pp
5Y change+4.4pp
10Y change-3.6pp

Illumina Inc's net profit margin was 17.9% in Q2 2026, showing the share of revenue converted to profit. This is down 4.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.6 percentage points.

Return on Equity
7.3%
YoY-3.1pp
QoQ+2.3pp
5Y change+4.3pp
10Y change+1.2pp

Illumina Inc's ROE was 7.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.

Capital Allocation

R&D Spending
$252.0M
YoY+2.0%
QoQ+5.0%
5Y CAGR+5.0%

Illumina Inc invested $252.0M in research and development in Q2 2026. This represents an increase of 2.0% from the same quarter a year earlier. Against the prior quarter it is up 5.0%.

Share Buybacks
$128.0M
YoY-65.4%
QoQ-47.1%

Illumina Inc spent $128.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 65.4% from the same quarter a year earlier. Against the prior quarter it is down 47.1%.

Capital Expenditures
$40.0M
YoY+33.3%
QoQ+5.3%
5Y CAGR-1.0%
10Y CAGR+3.1%

Illumina Inc invested $40.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 33.3% from the same quarter a year earlier. Against the prior quarter it is up 5.3%.

ILMN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-Q
Revenue$1.2B+9.4%$1.1B+4.8%$1.2B+5.0%$1.1B+0.4%$1.1B-4.8%$1.0B-3.3%$1.1B-1.3%$1.1B-8.2%
Cost of Revenue$389.0M+6.9%$370.0M+3.4%$400.0M+6.4%$351.0M+4.8%$364.0M-6.9%$358.0M-12.5%$376.0M-13.6%$335.0M-24.5%
Gross Profit$770.0M+10.8%$721.0M+5.6%$759.0M+4.3%$733.0M-1.6%$695.0M-3.6%$683.0M+2.4%$728.0M+6.4%$745.0M+1.8%
R&D Expenses$252.0M+2.0%$240.0M-4.8%$239.0M-5.2%$229.0M-9.5%$247.0M-24.0%$252.0M-25.7%$252.0M-20.0%$253.0M-29.3%
SG&A Expenses$273.0M+16.7%$272.0M+1.9%$308.0M+15.4%$277.0M+15.9%$234.0M+59.2%$267.0M-39.2%$267.0M-11.9%$239.0M-48.3%
Operating Income$245.0M+14.5%$209.0M+27.4%$202.0M+16.1%$227.0M-69.4%$214.0M+113.1%$164.0M+247.7%$174.0M+123.1%$741.0M+942.0%
EBITDA$315.0M+11.7%$278.0M+19.3%$268.0M+9.4%$294.0M-63.7%$282.0M+118.4%$233.0M+7866.7%$245.0M+137.9%$811.0M+3955.0%
Interest Expense$24.0M-4.0%$24.0M-4.0%$26.0M0.0%$25.0M-30.6%$25.0M+25.0%$25.0M+38.9%$26.0M+36.8%$36.0M+89.5%
Income Tax$53.0M-25.4%$23.0M-54.9%$44.0M$70.0M+366.7%$71.0M+491.7%$51.0M+200.0%$0+100.0%$15.0M-89.7%
Net Income$207.0M-11.9%$134.0M+2.3%$334.0M+79.6%$150.0M-78.7%$235.0M+111.8%$131.0M+204.0%$186.0M+124.7%$705.0M+401.3%
EPS (Basic)$1.37-8.1%$0.88+6.0%$2.17+85.5%$0.98-77.9%$1.49+111.9%$0.83+205.1%$1.17+124.5%$4.43+399.3%
EPS (Diluted)$1.35-9.4%$0.87+6.1%$2.16+84.6%$0.98-77.8%$1.49+111.9%$0.82+203.8%$1.17+124.5%$4.42+398.6%
Diluted Shares (Avg)153M-2.5%154M-3.1%N/A154M-3.8%157M-1.3%159M0.0%N/A160M+1.3%

ILMN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-Q
Total Assets$6.7B+9.2%$6.6B+6.1%$6.6B+5.4%$6.2B+2.7%$6.1B+0.1%$6.2B-38.4%$6.3B-37.7%$6.0B-48.9%
Current Assets$2.8B+7.3%$2.7B+2.4%$3.3B+19.8%$2.8B+17.8%$2.6B+7.4%$2.7B+3.5%$2.7B+9.6%$2.4B-26.4%
Cash & Equivalents$1.0B+11.3%$1.1B-2.2%$1.4B+25.8%$1.1B+20.8%$934.0M+1.5%$1.1B+0.5%$1.1B+21.6%$869.0M-44.0%
Short-Term Investments$128.0M-42.1%$66.0M-46.8%$215.0M+131.2%$228.0M+225.7%$221.0M+198.6%$124.0M$93.0M+1450.0%$70.0M+1066.7%
Inventory$629.0M+9.4%$611.0M+13.8%$564.0M+3.1%$590.0M+2.8%$575.0M+2.5%$537.0M-8.0%$547.0M-11.1%$574.0M-7.0%
Accounts Receivable$764.0M+9.0%$738.0M+5.6%$854.0M+16.2%$729.0M+4.3%$701.0M+9.4%$699.0M+10.1%$735.0M+6.5%$699.0M-5.7%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$1.3B+15.4%$1.3B+15.4%$1.1B0.0%$1.1B0.0%$1.1B+3.2%$1.1B-56.3%$1.1B-56.0%$1.1B-65.6%
Total Liabilities$3.8B-0.4%$3.9B+1.8%$3.9B-0.2%$3.8B-2.4%$3.8B-17.6%$3.8B-11.4%$3.9B-7.0%$3.9B-25.5%
Current Liabilities$1.6B+8.0%$1.6B+8.8%$1.6B+2.5%$2.0B+101.2%$1.5B-33.8%$1.4B-2.3%$1.5B+4.4%$975.0M-57.7%
Non-Current Liabilities$2.2B-5.7%$2.3B-2.4%$2.3B-2.0%$1.8B-37.1%$2.4B-2.8%$2.4B-16.2%$2.4B-13.1%$2.9B-0.1%
Total Equity$2.8B+25.7%$2.7B+13.0%$2.7B+14.7%$2.4B+12.0%$2.3B+57.2%$2.4B-58.7%$2.4B-59.8%$2.1B-67.6%
Retained Earnings-$51.0M+94.2%-$258.0M+76.8%-$392.0M+68.4%-$726.0M+49.2%-$876.0M+58.9%-$1.1B-666.2%-$1.2B-891.1%-$1.4B-256.8%

Not reported in any period shown, so not listed: Long-Term Debt.

ILMN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-Q
Operating Cash Flow$201.0M-14.1%$289.0M+20.4%$321.0M-11.8%$284.0M-10.1%$234.0M+192.5%$240.0M+211.7%$364.0M+161.9%$316.0M+201.0%
Depreciation & Amortization$70.0M+2.9%$69.0M0.0%$66.0M-7.0%$67.0M-4.3%$68.0M-35.2%$69.0M-36.1%$71.0M-34.3%$70.0M-35.2%
Stock-Based Compensation$72.0M+4.3%$60.0M-17.8%N/A$70.0M-16.7%$69.0M-37.3%$73.0M-24.0%N/A$84.0M-20.0%
Capital Expenditures$40.0M+33.3%$38.0M+18.8%$55.0M+89.7%$31.0M-3.1%$30.0M-3.2%$32.0M-11.1%$29.0M-35.6%$32.0M-31.9%
Free Cash Flow$161.0M-21.1%$251.0M+20.7%$266.0M-20.6%$253.0M-10.9%$204.0M+316.3%$208.0M+407.3%$335.0M+256.4%$284.0M+389.7%
Investing Cash Flow-$122.0M-149.0%-$366.0M-481.0%$108.0M+325.0%-$51.0M-24.4%-$49.0M-19.5%-$63.0M-31.3%-$48.0M+9.4%-$41.0M-10.8%
Financing Cash Flow-$129.0M+65.2%-$251.0M-28.7%-$63.0M-34.0%-$115.0M+65.4%-$371.0M-64.2%-$195.0M-657.1%-$47.0M+93.4%-$332.0M-10966.7%
Share Buybacks$128.0M-65.4%$242.0M+21.0%$42.0M+147.1%$130.0M+31.3%$370.0M$200.0M$17.0M$99.0M

Not reported in any period shown, so not listed: Dividends Paid.

ILMN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-Q
Gross Margin66.4%+0.8pp66.1%+0.5pp65.5%-0.4pp67.6%-1.4pp65.6%+0.8pp65.6%+3.6pp65.9%+4.8pp69.0%+6.7pp
Operating Margin21.1%+0.9pp19.2%+3.4pp17.4%+1.7pp20.9%-47.7pp20.2%15.8%+26.1pp15.8%+83.1pp68.6%+76.1pp
Net Margin17.9%-4.3pp12.3%-0.3pp28.8%+12.0pp13.8%-51.4pp22.2%12.6%+24.3pp16.9%+84.2pp65.3%+85.2pp
Return on Equity7.3%-3.1pp5.0%-0.5pp12.3%+4.4pp6.3%-26.9pp10.4%+148.9pp5.5%+7.7pp7.8%+20.6pp33.2%+36.8pp
Return on Assets3.1%-0.8pp2.0%-0.1pp5.0%+2.1pp2.4%-9.3pp3.9%+36.6pp2.1%+3.4pp2.9%+10.4pp11.7%+13.7pp
Current Ratio1.800.0x1.75-0.1x2.08+0.3x1.43-1.0x1.81+0.7x1.86+0.1x1.77+0.1x2.43+1.0x
Debt-to-Equity1.34-0.4x1.45-0.2x1.44-0.2x1.59-0.2x1.70-1.5x1.61+0.9x1.66+0.9x1.83+1.0x
Asset Turnover0.170.0x0.170.0x0.170.0x0.180.0x0.170.0x0.17+0.1x0.18+0.1x0.18+0.1x
FCF Margin13.9%-5.4pp23.0%+3.0pp22.9%-7.4pp23.3%-3.0pp19.3%+14.8pp20.0%+16.2pp30.3%+21.9pp26.3%+21.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Illumina Inc ILMN FY2025 $4.3B $850.0M 19.6% $41.2B 44/100
Waters Corp WAT FY2025 $3.2B $642.6M 20.3% $41.8B 71/100
Medpace Holdings, Inc. MEDP FY2025 $2.5B $451.1M 17.8% $16.7B 62/100
Labcorp Holdings Inc. LH FY2025 $14.0B $877.0M 6.3% $25.0B 50/100
Quest Diagnostics Inc. DGX FY2025 $11.0B $992.0M 9.0% $25.6B 54/100

Frequently Asked Questions

What is Illumina Inc's annual revenue?

Illumina Inc (ILMN) reported $4.3B in total revenue for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Illumina Inc's revenue growing?

Illumina Inc (ILMN) revenue declined by 0.7% year-over-year, from $4.4B to $4.3B in fiscal year 2025.

Is Illumina Inc profitable?

Yes, Illumina Inc (ILMN) reported a net income of $850.0M in fiscal year 2025, with a net profit margin of 19.6%.

Illumina Inc (ILMN) reported diluted earnings per share of $5.45 for fiscal year 2025. This represents a 170.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Illumina Inc (ILMN) had EBITDA of $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Illumina Inc (ILMN) had a gross margin of 66.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Illumina Inc (ILMN) had an operating margin of 18.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Illumina Inc (ILMN) had a net profit margin of 19.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Illumina Inc (ILMN) has a return on equity of 31.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Illumina Inc (ILMN) generated $931.0M in free cash flow during fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Illumina Inc (ILMN) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Illumina Inc (ILMN) had $6.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Illumina Inc (ILMN) invested $148.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Illumina Inc (ILMN) invested $967.0M in research and development during fiscal year 2025.

Yes, Illumina Inc (ILMN) spent $742.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Illumina Inc (ILMN) had 153M shares outstanding as of fiscal year 2025.

Illumina Inc (ILMN) had a current ratio of 2.08 as of fiscal year 2025, which is generally considered healthy.

Illumina Inc (ILMN) had a debt-to-equity ratio of 1.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Illumina Inc (ILMN) had a return on assets of 12.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Illumina Inc (ILMN) trades at 50.0x earnings, its market capitalization divided by net income of $825.0M net income, trailing 12 months to June 28, 2026. The market capitalization is $41.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Illumina Inc (ILMN) trades at 9.2x sales, its market capitalization divided by revenue of $4.5B revenue, trailing 12 months to June 28, 2026. The market capitalization is $41.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Illumina Inc (ILMN) has an Altman Z-Score of 7.59, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has an interest coverage ratio of 7.99x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top